Concepedia

Tatsushi Kodama

TK

6

Publications

1.3K

Citations

6

H-Index

2011

Active since

Affiliations

KAN Research Institute(Current)

Tatsushi Kodama is an author at KAN Research Institute specializing in medicine, drug discovery, and drug resistance.

Top concepts

Publications per year

2011–2019

6

Publications

6

CH5424802, a Selective ALK Inhibitor Capable of Blocking the Resistant Gatekeeper Mutant

Hiroshi Sakamoto, Toshiyuki Tsukaguchi, Sayuri Hiroshima et al. · Cancer Cell · 2011 · 618 citations · Full text

, , +8

Antitumor activity of the selective ALK inhibitor alectinib in models of intracranial metastases

Tatsushi Kodama, Masami Hasegawa, Kenji Takanashi et al. · Cancer Chemotherapy and Pharmacology · 2014 · 241 citations

, , +6

Selective ALK inhibitor alectinib with potent antitumor activity in models of crizotinib resistance

Tatsushi Kodama, Toshiyuki Tsukaguchi, Miyuki Yoshida et al. · Cancer Letters · 2014 · 195 citations

, , +9

Alectinib Shows Potent Antitumor Activity against <i>RET</i> -Rearranged Non–Small Cell Lung Cancer

Tatsushi Kodama, Toshiyuki Tsukaguchi, Yasuko Satoh et al. · Molecular Cancer Therapeutics · 2014 · 155 citations · Full text

Anti-GPRC5D/CD3 Bispecific T-Cell–Redirecting Antibody for the Treatment of Multiple Myeloma

Tatsushi Kodama, Yu Kochi, Waka Nakai et al. · Molecular Cancer Therapeutics · 2019 · 75 citations

Rows per page

1–5 of 6